当前位置:公众访问 >页面
简体中文 / English
1.Screening
1.1.Inclusion Criteria

Eligible participant has to fullfill all of the following items

/
/
/
/

1.2.Exclusion Criteria

Anyone with one of following items or more should be excluded:

/
/
/
/
/
/
/
/

2.Baseline
2.1.General information

Date of signing the informed consent

Date of birth

yyyy-mm-dd

Age

Years

Education background

Occupation

Other (Description)

2.2.Medical history

小时

Number of pregnancy

Number of delivery

If has delivery history, select following items

partus maturus

premature delivery

abortion

Last pregnancy

yyyy-mm-dd

Average times of menstrual onset a year

次/年

Average menstrual cycle

天(days)

Menarche time

岁(years)

The time of last Menstruation

年、月、日(yyyy-mm-dd)

The time of menstrual onset before the last one

年、月、日(yyyy-mm-dd)

年/月/日(yyyy-mm-dd)

Namy of the drug to be allergied

2.3.Physical examination

Vulva

Description in detail for abnormal

Vagina

Description in detail for abnormal

Uterine neck

Description in detail for abnormal

Corpus uteri

Description in detail for abnormal

Adnexa uteri

Left side

Description in detail for abnormal

Right side

Description in detail for abnormal

Weight

kg

Hight

mm

Systolic pressure (SP)

mmHg

Diastolic pressure

mmHg

Temperature

degree Celsius

Pulse rate

次/分

Breath frequency

次/分

Doctor signature

Date

yyyy-mm-dd

2.4.Blood Routine Tests

WBC

×109 /L

NEUT%

%

LY%

%

MONO%

RBC

×10^12 /L

HGB

g/L

PLT

×10^9 /L

Researcher signature

Date

yyyy-mm-dd

2.5.Urine Routine Test

Acidity and allkalinity

pH value

Urine protein

Urine red cell

Urine WBC

Urine glucos

Urine Bilirubin

Urine HCG

KET

SG

UBG

NIT

Date of test

yyyy-mm-dd

2.6.Blood Electrolytes Tests

Date of test

yyyy-mm-dd

K

mmol/L

Na

mmol/L

Cl

mmol/L

Ca

mmol/L

P

mmol/L

2.7.Coagulation Function Tests

Date of examination

yyyy-mm-dd

Prothrombin time

Thrombin time (TT)

Activated partial thromboplastin time (APTT)

Fibrinogen (FIB)

g/L

2.8.Serum Liver Function Tests

ALT

IU/L

AST

IU/L

GGT

U/L

Serum bilirubin

μmol/L

Indirect bilirubin

umol/L

Direct bilirubin

umol/L

Serum albumin

g/L

Serum globulin

g/L

Serum total protein

g/L

Date of test

yyyy-mm-dd

2.9.HBV/HCV/HIV/Syphilis Markers Test
2.2.9.2.9.1、HBV Markers Test

Date of test

yyyy-mm-dd

2.2.9.2.9.2、HCV Marker Test

Date of test

yyyy-mm-dd

2.2.9.2.9.3、HIV Marker Test

Date of test

yyyy-mm-dd

2.2.9.2.9.4、Syphilis Marker Test

Date of test

yyyy-mm-dd

2.10.Renel Function Test

SCr

μmol/L

Blood urea

mmol/L

Blood uric acid

μmol/L

Date of test

yyyy-mm-dd

2.11.D-dimer

D-dimer value

ug/mL

Date of test

2.12.hCG Test

Urine pregnancy test

Blood HCG concentration

mIU/mL

Date of test

yyyy-mm-dd

2.13.Image Examinations
2.2.13.2.13.1、Ultrasound

Size of the ulcer

cm*cm

Uterine echo distribution

Endometrial thickness

mm

Left ovary size

cm ×cm

Shape of Left ovary

Size of the Ovarian cyst

Right ovary size

cm ×cm

Shape of right ovary

Size of Ovarian cyst

Description of other abnormal findings

Diagnosis of the Ultrasound B

Doctor signature

Date of examination

yyyy-mm-dd

2.2.13.2.13.2、Other examination
2.14.Visual Analogue Scale

Pain Visual Analogue Score

2.15.Blood Gas Analysis

PH

PCO2

mmHg

P02

mmHg

SO2

HCO3

mmol/l

SBE

mmol/l

LAC

mmol/L

Date of examination

(yyyy-mm-dd)

3.In the process of the treatment
3.1.Treatment Record

右卵巢巧囊

7*7*6 cm

0 °

/

刘义彬

2024-1-19

4.Follow-up
4.1.D-dimer

D-dimer value

0.33 ug/mL

Date of test

2024-1-20

4.2.Physical examination

Body temperature

36.4

Systolic pressure (SP)

92 mmHg

Diastolic pressure (DP)

58 mmHg

Heart Rate, HR

84 次/分

Pulse

84 次/秒

4.3.Blood Routine Tests

WBC

13.3 ×109 /L

NEUT%

89.57 %

LY%

6.16 %

MONO%

3.95

RBC

3.95 ×10^12 /L

HGB

116 g/L

PLT

190 ×10^9 /L

Date

2024-1-20 yyyy-mm-dd

4.4.Visual Analogue Scale

/

Pain Visual Analogue Score

Occasionally very slight pain

5.Speciman management system

sample collection

Collected

Volume

1 ml

Time of collection

2024-1-20 yyyy-mm-dd-hh-min.

Label Number of the sample

2558621

6.ADR/ADE management system

Date received at DCC

-- yyyymmdd

Report type

Name of this event

--

SAE start date

-- yyyymmdd

SAE stop date

-- yyyymmdd

Was this an unanticipated adverse event

Attribution to Study Drug

Outcome Type(check all that apply)

Recovery Description: (check only one)

Please provide a brief narrative of the SAE occurrence below

--

Name of the recorder

--

Data

-- yyyymmdd

Site Investigator’s signature

--

Data

-- yyyymmdd